Psoriatic Arthritis Clinical Trials
Psoriatic Arthritis clinical trials study new biologics, small-molecule drugs, and treatment approaches for psoriatic Arthritis and related immune or inflammatory conditions. Corterve gathers actively recruiting Psoriatic Arthritis studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Psoriatic Arthritis studies
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesNCT06671496PHASE3TakedaMesa, Arizona
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345PHASE1National Cancer Institute (NCI)Birmingham, Alabama
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesNCT06671483PHASE3TakedaChandler, Arizona
- A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabNCT06100744PHASE3AbbVieLittle Rock, Arkansas
- A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic ArthritisNCT06454188PHASE4CARE ARTHRITIS LTD.Cleveland, Ohio
- Rheumatology Diet StudyNCT06339957University of Central FloridaOrlando, Florida
- A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic ArthritisNCT06869551PHASE3Bristol-Myers SquibbLancaster, California
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectNCT02103361University of California, San DiegoLa Jolla, California
- Continuation Study of Zasocitinib in Adults With Psoriatic ArthritisNCT07286058PHASE3TakedaFountain Valley, California
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNCT04751396M.D. Anderson Cancer CenterHouston, Texas
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)NCT06864026PHASE4Eli Lilly and CompanyAvondale, Arizona
- Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).NCT06751238PHASE1Novartis PharmaceuticalsGainesville, Florida
Psoriatic Arthritis trials by state
Psoriatic Arthritis trials by metro
Frequently asked questions
- How do I find recruiting Psoriatic Arthritis clinical trials?
- Corterve aggregates actively recruiting Psoriatic Arthritis studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Psoriatic Arthritis clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Psoriatic Arthritis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.